FDA pharmacologic class
Anti-coagulant
9 medicines are in FDA's class of anti-coagulants: heparin, potassium citrate (Urocit-K), argatroban, trisodium citrate (Tricitrasol), bivalirudin, dalteparin (Fragmin), edetate, lefamulin (Xenleta) and 1 more; 16 combination products also contain one. 8 of the 25 are listed from generic labelers (FDA NDC Directory, October 8, 2026). The lowest pharmacy cost is potassium citrate er 10 meq tablet at $0.175 per tablet (NADAC).
Which medicines are anti-coagulant?
| Medicine | Brand names | Generic labelers (all forms) | Pharmacy cost | Boxed warning | Shortage | Recalls since 2012 |
|---|---|---|---|---|---|---|
| Heparin | none listed | 18 labelers | $1.18 per mL 5,000 unit/mL vial | No | In shortage | 18 |
| Potassium citrate | Urocit-K | 12 labelers | $0.175 per tablet 10 mEq tablet | No | No current entry | 2 |
| Argatroban | none listed | 8 labelers | n/a | No | No current entry | 1 |
| Trisodium citrate | Tricitrasol | 2 labelers | n/a | No | No current entry | 0 |
| Bivalirudin | none listed | 9 labelers | n/a | No | No current entry | 1 |
| Dalteparin | Fragmin | none listed | n/a | Yes | No current entry | 0 |
| Dextrose and heparin | none listed | none listed | n/a | No | No current entry | 3 |
| Citric acid and lactic acid l- and potassium bitartrate | Phexxi, Phexx | none listed | $6.05 per gram 1.8-1-0.4% vaginal gel | No | No current entry | 0 |
| Anhydrous citric acid and magnesium oxide and sodium picosulfate | Clenpiq | none listed | $0.518 per mL 175 mL solution | No | No current entry | 0 |
| Citric acid and urea c 13 | Idkit | none listed | n/a | No | No current entry | 0 |
| Edetate | none listed | 1 labeler | n/a | Yes | No current entry | 4 |
| Heparin and taurolidine | Defencath | none listed | n/a | No | No current entry | 0 |
| Adenine, anhydrous citric acid, dextrose, sodium phosphate monobasic and trisodium citrate | Cpda, Teruflex | none listed | n/a | No | No current entry | 0 |
| Citric acid, dextrose, sodium citrate and sodium phosphate monobasic | Pall | none listed | n/a | No | No current entry | 0 |
| Sodium acetate, sodium chloride and 3 other ingredients | Intersol, Solucion | none listed | n/a | No | No current entry | 0 |
| Adenine, citric acid, dextrose, sodium citrate and sodium phosphate monobasic | Leukotrap | none listed | n/a | No | No current entry | 0 |
| Citric acid and dextrose and sodium citrate | Acd | 3 labelers | n/a | No | No current entry | 0 |
| Adenine, citric acid and 4 other ingredients | Additive | none listed | n/a | No | No current entry | 0 |
| Anhydrous citric acid and dextrose and sodium citrate | Acd-A | none listed | n/a | No | No current entry | 0 |
| Anhydrous citric acid, dextrose, sodium phosphate monobasic and trisodium citrate | none listed | none listed | n/a | No | No current entry | 0 |
| Anhydrous citric acid and dextrose and trisodium citrate | Acd | none listed | n/a | No | No current entry | 0 |
| Citric acid and dextrose and trisodium citrate | Acd | 2 labelers | n/a | No | No current entry | 0 |
| Lefamulin | Xenleta | none listed | n/a | No | No current entry | 0 |
| Anhydrous citric acid | none listed | none listed | n/a | No | No current entry | 0 |
| Anhydrous citric acid and gluconolactone and magnesium carbonate | Renacidin | none listed | n/a | No | No current entry | 0 |
Source: FDA Established Pharmacologic Class (NDC Directory, openFDA); CMS NADAC of October 7, 2026; FDA shortages and recalls (FDA files October 8, 2026)
What do pharmacies pay?
Each medicine's most widely listed form, per unit, in the NADAC survey: what pharmacies paid, not what a patient pays; strengths differ, so compare like with like.
Source: CMS National Average Drug Acquisition Cost (NADAC) survey, October 7, 2026: what retail pharmacies paid per unit; not a counter price